(HealthDay)—Use of D-dimer levels to exclude pulmonary embolism (PE) has limited clinical utility and may be inappropriate in patients hospitalized with COVID-19, many of whom have increased plasma ...
A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a ...
D-dimer and Fibrin/Fibrinogen Degradation Products (FDP) are both laboratory tests used to evaluate the blood coagulation and ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...
Synopsis: A number of recent studies have attempted to validate less invasive protocols for the evaluation of patients with thromboembolic disease. As with most of these studies, the protocol in this ...
Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?
Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...
In patients with antihistamine-resistant chronic spontaneous urticaria, omalizumab treatment is linked to clinical ...
—Can an age-adjusted cutoff level for D-dimer enable clinicians to safely rule out deep vein thrombosis (DVT) in some adults? That was the question at the core of a multicenter, multinational, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results